Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
Helen Chen, Olof Mollstedt · 2 co-founders
Profile coverage5 of 8 · missing Signals, Customers, Stack / tools · last run 8/10/2026
About
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.